The impact of sarcopenia on esophagectomy for cancer: a systematic review and meta-analysis

Carregando...
Imagem de Miniatura
Citações na Scopus
2
Tipo de produção
article
Data de publicação
2023
Título da Revista
ISSN da Revista
Título do Volume
Editora
BMC
Autores
PARK, Amanda
ORLANDINI, Marina Feliciano
Citação
BMC SURGERY, v.23, n.1, article ID 240, 13p, 2023
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
BackgroundEsophagectomy is the gold-standard treatment for locally advanced esophageal cancer but has high morbimortality rates. Sarcopenia is a common comorbidity in cancer patients. The exact burden of sarcopenia in esophagectomy outcomes remains unclear. Therefore, this systematic review and meta-analysis were performed to establish the impact of sarcopenia on postoperative outcomes of esophagectomy for cancer.MethodsWe performed a systematic review and meta-analysis comparing sarcopenic with non-sarcopenic patients before esophagectomy for cancer (Registration number: CRD42021270332). An electronic search was conducted on Embase, PubMed, Cochrane, and LILACS, alongside a manual search of the references. The inclusion criteria were cohorts, case series, and clinical trials; adult patients; studies evaluating patients with sarcopenia undergoing esophagectomy or gastroesophagectomy for cancer; and studies that analyze relevant outcomes. The exclusion criteria were letters, editorials, congress abstracts, case reports, reviews, cross-sectional studies, patients undergoing surgery for benign conditions, and animal studies. The meta-analysis was synthesized with forest plots.ResultsThe meta-analysis included 40 studies. Sarcopenia was significantly associated with increased postoperative complications (RD: 0.08; 95% CI: 0.02 to 0.14), severe complications (RD: 0.11; 95% CI: 0.04 to 0.19), and pneumonia (RD: 0.13; 95% CI: 0.09 to 0.18). Patients with sarcopenia had a lower probability of survival at a 3-year follow-up (RD: -0.16; 95% CI: -0.23 to -0.10).ConclusionPreoperative sarcopenia imposes a higher risk for overall complications and severe complications. Besides, patients with sarcopenia had a lower chance of long-term survival.
Palavras-chave
Sarcopenia, Esophageal neoplasms, Esophagectomy, Systematic review, Meta-analysis
Referências
  1. Andersen KS, 2017, INT J SURG PROTOC, V4, P1, DOI 10.1016/j.isjp.2017.03.001
  2. Barchitta M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20051119
  3. BEHNE THAYSE EMANUELLI GODOY, 2020, Rev. Col. Bras. Cir., V47, pe20202528, DOI 10.1590/0100-6991e-20202528
  4. Booth A, 2014, 3 INT S SYST REV MET
  5. Boshier PR, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/doy047
  6. Brower R., 2009, CRIT CARE MED, DOI [10.1097/CCM.0b013e3181b6e30a, DOI 10.1097/CCM.0B013E3181B6E30A, 10.1097/ccm.0b013e3181b6e30a]
  7. Bruunsgaard H, 2000, IMMUNOL CELL BIOL, V78, P523, DOI 10.1046/j.1440-1711.2000.00965.x
  8. Chastre J, 1998, AM J RESP CRIT CARE, V157, P1165, DOI 10.1164/ajrccm.157.4.9708057
  9. Chen S, 2016, ONCOTARGET, V7, P62123, DOI 10.18632/oncotarget.11389
  10. Childs CE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11081933
  11. Colcord ME, 2021, J GASTROINTEST SURG, V25, P3040, DOI 10.1007/s11605-021-05183-y
  12. Connolly GC, 2010, THROMB RES, V126, P113, DOI 10.1016/j.thromres.2010.05.012
  13. Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322
  14. Deans C, 2005, CURR OPIN CLIN NUTR, V8, P265, DOI 10.1097/01.mco.0000165004.93707.88
  15. Dellis Spilios, 2018, J Frailty Sarcopenia Falls, V3, P1, DOI 10.22540/JFSF-03-001
  16. Duan H, 2015, WORLD J GASTROENTERO, V21, P5591, DOI 10.3748/wjg.v21.i18.5591
  17. Durham WJ, 2009, CURR OPIN CLIN NUTR, V12, P72, DOI 10.1097/MCO.0b013e32831cef61
  18. Elliott JA, 2017, ANN SURG, V266, P822, DOI 10.1097/SLA.0000000000002398
  19. Evans RPT, 2020, DIS ESOPHAGUS, V33, DOI 10.1093/dote/doz007
  20. Fehrenbach U, 2021, CANCERS, V13, DOI 10.3390/cancers13122921
  21. Grotenhuis BA, 2016, WORLD J SURG, V40, P2698, DOI 10.1007/s00268-016-3603-1
  22. Harada K, 2016, DIS ESOPHAGUS, V29, P627, DOI 10.1111/dote.12381
  23. Haskins IN, 2017, CLIN NUTR, V36, P1333, DOI 10.1016/j.clnu.2016.08.023
  24. Huddy JR, 2018, DIS ESOPHAGUS, V31, DOI 10.1093/dote/dox110
  25. Ida S, 2015, ANN SURG ONCOL, V22, P4432, DOI 10.1245/s10434-015-4559-3
  26. Ishida T, 2019, SURGERY, V166, P1041, DOI 10.1016/j.surg.2019.07.033
  27. Järvinen T, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-018-1327-4
  28. Joliat GR, 2022, PERIOPER MED-LONDON, V11, DOI 10.1186/s13741-022-00238-3
  29. Kakehi S, 2022, WORLD J MENS HEALTH, V40, P1, DOI 10.5534/wjmh.200190
  30. Kamada T, 2022, ANTICANCER RES, V42, P301, DOI 10.21873/anticanres.15486
  31. Kamitani N, 2019, SURG TODAY, V49, P1022, DOI 10.1007/s00595-019-01846-1
  32. Kawakita Y, 2020, WORLD J SURG, V44, P1559, DOI 10.1007/s00268-019-05344-w
  33. Kinoshita A, 2012, BRIT J CANCER, V107, P988, DOI 10.1038/bjc.2012.354
  34. Kotta PA, 2021, RESP CARE, V66, P327, DOI 10.4187/respcare.07972
  35. Kudou K, 2017, ANN SURG ONCOL, V24, P1804, DOI 10.1245/s10434-017-5811-9
  36. Kurita D, 2022, ESOPHAGUS-TOKYO, V19, P586, DOI 10.1007/s10388-022-00925-6
  37. Li C, 2013, SURG ENDOSC, V27, P1072, DOI 10.1007/s00464-012-2560-5
  38. Low DE, 2019, WORLD J SURG, V43, P299, DOI 10.1007/s00268-018-4786-4
  39. Madden AM, 2016, J HUM NUTR DIET, V29, P7, DOI 10.1111/jhn.12278
  40. Maeda N, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01908-6
  41. Makiura D, 2018, ANN SURG ONCOL, V25, P456, DOI 10.1245/s10434-017-6294-4
  42. Makiura D, 2016, J GERIATR ONCOL, V7, P430, DOI 10.1016/j.jgo.2016.07.003
  43. Marcell TJ, 2003, J GERONTOL A-BIOL, V58, P911, DOI 10.1093/gerona/58.10.M911
  44. Matsunaga T, 2019, ANTICANCER RES, V39, P449, DOI 10.21873/anticanres.13133
  45. Mayanagi S, 2021, DIS ESOPHAGUS, V34, DOI 10.1093/dote/doaa121
  46. McGovern J, 2021, J CACHEXIA SARCOPENI, V12, P1408, DOI 10.1002/jcsm.12831
  47. Menezes TM, 2020, J SURG ONCOL, V121, P814, DOI 10.1002/jso.25822
  48. Meyer CP, 2017, AM J SURG, V214, P871, DOI 10.1016/j.amjsurg.2016.11.023
  49. Miyata H, 2011, EXP THER MED, V2, P879, DOI 10.3892/etm.2011.308
  50. Molenaar CJL, 2022, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013259.pub2
  51. Murnane LC, 2021, ANZ J SURG, V91, P2683, DOI 10.1111/ans.17203
  52. Nagata K, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011450
  53. Nakashima Y, 2018, ANN SURG, V267, P1100, DOI 10.1097/SLA.0000000000002252
  54. Nambara M, 2021, WORLD J SURG, V45, P3108, DOI 10.1007/s00268-021-06223-z
  55. Nishigori T, 2016, J SURG ONCOL, V113, P678, DOI 10.1002/jso.24214
  56. Nishijima M, 2020, LANGENBECK ARCH SURG, V405, P613, DOI 10.1007/s00423-020-01925-9
  57. Oguma J, 2019, DIS ESOPHAGUS, V32, DOI 10.1093/dote/doy104
  58. Page MJ, 2021, PLOS MED, V18, DOI [10.1136/bmj.n71, 10.1136/bmj.n160, 10.1016/j.rec.2021.07.010, 10.1016/j.jclinepi.2021.03.001, 10.1371/journal.pmed.1003583, 10.1186/s13643-021-01626-4, 10.1016/j.ijsu.2021.105906, 10.26633/RPSP.2022.112, 10.1016/j.recesp.2021.06.016]
  59. Paireder M, 2017, EJSO-EUR J SURG ONC, V43, P478, DOI 10.1016/j.ejso.2016.11.015
  60. Panje CM, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1372-3
  61. Pedersen BK, 2003, SCAND J MED SCI SPOR, V13, P56, DOI 10.1034/j.1600-0838.2003.20218.x
  62. Purnak T, 2013, BEST PRACT RES CL GA, V27, P619, DOI 10.1016/j.bpg.2013.06.018
  63. Saeki H, 2018, WORLD J SURG, V42, P2894, DOI 10.1007/s00268-018-4554-5
  64. Sakai M, 2021, AM J SURG, V221, P149, DOI 10.1016/j.amjsurg.2020.05.029
  65. Schmidt HM, 2017, ANN SURG, V266, P814, DOI 10.1097/SLA.0000000000002445
  66. Seiler WO, 2001, NUTRITION, V17, P496, DOI 10.1016/S0899-9007(01)00558-5
  67. Shimura M, 2023, PANCREATOLOGY, V23, P65, DOI 10.1016/j.pan.2022.11.010
  68. Siegal SR, 2018, AM J SURG, V215, P813, DOI 10.1016/j.amjsurg.2017.12.017
  69. Silver JK, 2013, AM J PHYS MED REHAB, V92, P715, DOI 10.1097/PHM.0b013e31829b4afe
  70. Soares JDP, 2020, CURR PHARM DESIGN, V26, P970, DOI 10.2174/1381612826666200218100420
  71. Soma D, 2019, DIS ESOPHAGUS, V32, DOI 10.1093/dote/doy092
  72. Srpcic M, 2020, RADIOL ONCOL, V54, P237, DOI 10.2478/raon-2020-0016
  73. Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z
  74. Steenhagen E, 2019, J THORAC DIS, V11, pS645, DOI 10.21037/jtd.2018.11.33
  75. Sugimura K, 2022, ANN GASTROENT SURG, V6, P623, DOI 10.1002/ags3.12560
  76. Tamandl D, 2016, EUR RADIOL, V26, P1359, DOI 10.1007/s00330-015-3963-1
  77. Tazreean R, 2021, J COMP EFFECT RES, V11, P121, DOI 10.2217/cer-2021-0258
  78. Tomaszek S, 2009, GASTROENTEROL CLIN N, V38, P169, DOI 10.1016/j.gtc.2009.01.010
  79. Traeger L, 2023, TECH COLOPROCTOL, DOI 10.1007/s10151-023-02812-3
  80. Tustumi F, 2020, J SURG ONCOL, V121, P784, DOI 10.1002/jso.25778
  81. Tustumi F, 2016, ABCD-ARQ BRAS CIR DI, V29, P138, DOI 10.1590/0102-6720201600030003
  82. Uemura S, 2021, ASIAN J ENDOSC SURG, V14, P739, DOI 10.1111/ases.12933
  83. van Stijn MFM, 2013, JPEN-PARENTER ENTER, V37, P37, DOI 10.1177/0148607112445900
  84. Velloso CP, 2008, BRIT J PHARMACOL, V154, P557, DOI 10.1038/bjp.2008.153
  85. Wakabayashi H, 2014, J CACHEXIA SARCOPENI, V5, P269, DOI 10.1007/s13539-014-0162-x
  86. Wakefield CJ, 2021, J THORAC DIS, V13, P861, DOI 10.21037/jtd-20-2608
  87. Wang PY, 2020, INT J SURG, V83, P206, DOI 10.1016/j.ijsu.2020.09.049
  88. Wang PY, 2020, ANN SURG ONCOL, V27, P3041, DOI 10.1245/s10434-020-08236-9
  89. Watanabe A, 2022, ANN SURG ONCOL, V29, P3670, DOI 10.1245/s10434-022-11337-2
  90. Woo HY, 2020, CLIN NUTR, V39, P2764, DOI 10.1016/j.clnu.2019.12.002
  91. Xu JX, 2019, J THORAC DIS, V11, P2535, DOI 10.21037/jtd.2019.05.55
  92. Yassaie SS, 2019, ANZ J SURG, V89, P515, DOI 10.1111/ans.15106